Trials / Terminated
TerminatedNCT05605678
Hemophilia Non-Interventional Study Prior to SerpinPC Intervention (PRESent-5)
A Global, Non-interventional Study to Prospectively Evaluate Bleeding Episodes and Treatment Use in Patients with Hemophilia
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 108 (actual)
- Sponsor
- ApcinteX Ltd · Industry
- Sex
- Male
- Age
- 12 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to obtain prospective baseline documentation of annualized bleeding rates (ABRs) and treatment under standard-of-care (SOC) therapy among participants with hemophilia A or B. Participants in the study may be eligible to enroll in future planned interventional studies to be conducted by Sponsor.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No Intervention | This is a non-interventional study. |
Timeline
- Start date
- 2022-12-09
- Primary completion
- 2024-11-29
- Completion
- 2024-11-29
- First posted
- 2022-11-04
- Last updated
- 2025-02-07
Locations
45 sites across 16 countries: United States, Armenia, Australia, Brazil, Canada, Egypt, France, Germany, India, Italy, Poland, South Africa, Spain, Taiwan, Turkey (Türkiye), United Kingdom
Source: ClinicalTrials.gov record NCT05605678. Inclusion in this directory is not an endorsement.